Gene Predictisis acquired by NIMGenetics, a leading Spanish biotech company in the field of human genetic diagnostics that is continuing this way its expansion in Europe. This acquisition gives to Gene Predictis an opportunity to accelerate its expansion on the international market.
The synergies of both portfolios, as well as combined technology expertise will allow not only to better serve medical diagnostic market, but also to extend our services to the pharmaceutical and biotech companies globally.
|Contact Us||+41 21 691 43 firstname.lastname@example.org||EPFL Innovation Park|
|+41 21 691 43 75|
|EPFL Innovation Park|